Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCHAMPIONS ONCOLOGY, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CHAMPIONS ONCOLOGY, INC.

$4.84Close · Oct 9, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $15.23M. Net result −$426K. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $15.23M. Running result $15.23M. Pharmacology Services: $14.16M. Product And Service Other: $183K. Translational Oncology Solutions TOS License Revenue: $893K.
  • Cost of revenue: −$7.53M. Running result $7.7M.
  • Gross profit: $7.7M. Running result $7.7M.
  • Operating costs: −$8.11M. Running result −$409K.
  • Operating income: −$409K. Running result −$409K.
  • Other expense: −$6K. Running result −$415K.
  • Pre-tax loss: −$415K. Running result −$415K.
  • Income tax expense: −$11K. Running result −$426K.
  • Net loss: −$426K. Running result −$426K.